A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants

dc.contributor.author	Martinón Torres, Federico
dc.contributor.author	Diez Domingo, Javier
dc.date.accessioned	2017-06-07T07:20:39Z
dc.date.available	2017-06-07T07:20:39Z
dc.date.issued	2014
dc.identifier.issn	0264-410X
dc.identifier.uri	http://hdl.handle.net/20.500.11940/5366
dc.language.iso	eng
dc.title	A randomized, phase 1/2 trial of the safety, tolerability, and immunogenicity of bivalent rLP2086 meningococcal B vaccine in healthy infants
dc.type	Artigo	es
dc.authorsophos	Martinon-Torres, F.
dc.authorsophos	Gimenez-Sanchez, F.
dc.authorsophos	Bernaola-Iturbe, E.
dc.authorsophos	Diez-Domingo, J.
dc.authorsophos	Jiang, Q.
dc.authorsophos	Perez, J. L.
dc.identifier.doi	10.1016/j.vaccine.2014.07.049
dc.identifier.isi	342269800010
dc.identifier.pmid	25077420
dc.identifier.sophos	14873
dc.issue.number	40
dc.journal.title	Vaccine
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Pediatría
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago::IDIS.- Instituto de investigaciones sanitarias de Santiago
dc.page.initial	5206
dc.page.final	11
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	32

Files in this item

Files	Size	Format	View
There are no files associated with this item.